\-\ Texto\\:\\ \ \(0\)\
\-\ pain\\ and\\ swelling\\ anterior\\ shin\\.\ \(0\)\
\-\ wide\\ surgical\\ excision\\.\\ \\ no\\ mets\\ at\\ time\\ of\\ diagnosis\\,\\ reflecting\\ a\\ positive\\ prognosis\\.\ \(0\)\
\-\ a\\ mixed\\ lytic\\ and\\ sclerotic\\ lesion\\ is\\ noted\\ in\\ the\\ anterior\\ tibial\\ diaphysis\\,\\ predominantly\\ cortical\\.\\ \\ the\\ lesion\\ demonstrates\\ increased\\ radionuclide\\ uptake\\ and\\ is\\ fdg\\ avid\\.\ \(0\)\
\-\ adamantinoma\ \(2\)\
\-\ \\â\\€\\¢\\ adamantinoma\\ \ \(0\)\
\-\ \\â\\€\\¢\\ osteofibrous\\ dysplasia\ \(0\)\
\-\ \\â\\€\\¢\\ nonossifying\\ fibroma\ \(0\)\
\-\ \\â\\€\\¢\\ fibrous\\ dysplasia\ \(2\)\
\-\ \\â\\€\\¢\\ chondromyxoid\\ fibroma\\ \ \(0\)\
\-\ \\â\\€\\¢\\ intraosseous\\ hemangioma\ \(0\)\
\-\ 22\\ y\\.o\\.\\ woman\\ \\-\\ track\\ team\\ member\\ \\-\\ with\\ shin\\ pain\\ x\\ 4\\ weeks\ \(1\)\
\-\ adamantinomas\\ have\\ a\\ mixed\\ lytic\\ and\\ sclerotic\\,\\ sometimes\\ expansile\\ \\ \\"soap\\ bubbly\\"\\,\\ appearance\\ on\\ plain\\ film\\ and\\ ct\\.\\ \\ \\ the\\ location\\ is\\ very\\ specific\\ \\(90\\%\\ anterior\\ tibial\\ cortex\\)\\.\\ \\ tc99m\\-hdp\\ bone\\ scan\\ shows\\ increased\\ radiotracer\\ uptake\\,\\ as\\ the\\ radiotracer\\ localizes\\ to\\ osteoblastic\\ activity\\.\\ \\ pet\\ is\\ used\\ to\\ search\\ for\\ possible\\ mets\\.\\ \\ both\\ the\\ primary\\ and\\ metastatic\\ lesions\\ display\\ increased\\ f18\\-fluorodeoxyglucose\\ metabolism\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ adamantinoma\\:\\ 0\\.269187926472343\ \(0\)\
\-\ shin\\:\\ 0\\.22268019800458771\ \(0\)\
\-\ mets\\:\\ 0\\.1967410422347209\ \(0\)\
\-\ fibroma\\:\\ 0\\.19250411070755336\ \(0\)\
\-\ radiotracer\\:\\ 0\\.16704957345095034\ \(0\)\
\-\ tibial\\:\\ 0\\.1652357136269713\ \(0\)\
\-\ lytic\\:\\ 0\\.16120032511366916\ \(0\)\
\-\ sclerotic\\:\\ 0\\.16053598192720847\ \(0\)\
\-\ anterior\\:\\ 0\\.16027585748431494\ \(0\)\
\-\ mixed\\:\\ 0\\.15841196672361385\ \(0\)\
\-\ increased\\:\\ 0\\.15522677865460088\ \(0\)\
\-\ adamantinomas\\:\\ 0\\.15302221463995\ \(0\)\
\-\ uptake\\:\\ 0\\.14715333256549473\ \(0\)\
\-\ dysplasia\\:\\ 0\\.14656987030069027\ \(0\)\
\-\ osteofibrous\\:\\ 0\\.14139528252301117\ \(0\)\
\-\ soap\\:\\ 0\\.13765224641722038\ \(0\)\
\-\ localizes\\:\\ 0\\.1345939632361715\ \(0\)\
\-\ member\\:\\ 0\\.13200822164997097\ \(0\)\
\-\ reflecting\\:\\ 0\\.12976835040607235\ \(0\)\
\-\ bubbly\\:\\ 0\\.12779264394933185\ \(0\)\
\-\ chondromyxoid\\:\\ 0\\.12162438535123811\ \(0\)\
\-\ and\\:\\ 0\\.11863363142631907\ \(0\)\
\-\ radionuclide\\:\\ 0\\.11712449377116123\ \(0\)\
\-\ display\\:\\ 0\\.11357997024619249\ \(0\)\
\-\ nonossifying\\:\\ 0\\.11065534607755191\ \(0\)\
\-\ intraosseous\\:\\ 0\\.10936439254555337\ \(0\)\
\-\ metabolism\\:\\ 0\\.10936439254555337\ \(0\)\
\-\ avid\\:\\ 0\\.10816573150116161\ \(0\)\
\-\ osteoblastic\\:\\ 0\\.10704704256203183\ \(0\)\
\-\ track\\:\\ 0\\.1065144861721947\ \(0\)\
\-\ is\\:\\ 0\\.10481668154760505\ \(0\)\
\-\ fdg\\:\\ 0\\.10363184980346468\ \(0\)\
\-\ team\\:\\ 0\\.10235725328622484\ \(0\)\
\-\ search\\:\\ 0\\.09971316688535502\ \(0\)\
\-\ the\\:\\ 0\\.0954637899452656\ \(0\)\
\-\ diaphysis\\:\\ 0\\.0931464544620678\ \(0\)\
\-\ wide\\:\\ 0\\.09268047679503004\ \(0\)\
\-\ lesion\\:\\ 0\\.09174767606099522\ \(0\)\
\-\ sometimes\\:\\ 0\\.08954577381298467\ \(0\)\
\-\ pet\\:\\ 0\\.08861879115825333\ \(0\)\
\-\ expansile\\:\\ 0\\.08658306990652402\ \(0\)\
\-\ prognosis\\:\\ 0\\.0842039935707135\ \(0\)\
\-\ predominantly\\:\\ 0\\.08379317832815417\ \(0\)\
\-\ hemangioma\\:\\ 0\\.08048870621782785\ \(0\)\
\-\ cortex\\:\\ 0\\.07791884169604585\ \(0\)\
\-\ 90\\:\\ 0\\.07645930265147736\ \(0\)\
\-\ excision\\:\\ 0\\.07544237813350507\ \(0\)\
\-\ 22\\:\\ 0\\.07536035294655637\ \(0\)\
\-\ fibrous\\:\\ 0\\.07432899494083921\ \(0\)\
\-\ specific\\:\\ 0\\.07250788973799638\ \(0\)\
\-\ used\\:\\ 0\\.07163368982137822\ \(0\)\
\-\ film\\:\\ 0\\.0715031512847125\ \(0\)\
\-\ activity\\:\\ 0\\.07025077004290609\ \(0\)\
\-\ cortical\\:\\ 0\\.06869596598998216\ \(0\)\
\-\ very\\:\\ 0\\.0686410588466654\ \(0\)\
\-\ pain\\:\\ 0\\.0684797070404428\ \(0\)\
\-\ location\\:\\ 0\\.06662884722359996\ \(0\)\
\-\ possible\\:\\ 0\\.06483237053453854\ \(0\)\
\-\ swelling\\:\\ 0\\.06440113554334062\ \(0\)\
\-\ plain\\:\\ 0\\.0631306930918243\ \(0\)\
\-\ positive\\:\\ 0\\.06305194122273278\ \(0\)\
\-\ primary\\:\\ 0\\.05883636352209364\ \(0\)\
\-\ appearance\\:\\ 0\\.05768518090539696\ \(0\)\
\-\ weeks\\:\\ 0\\.05734629832295693\ \(0\)\
\-\ scan\\:\\ 0\\.056769244755711434\ \(0\)\
\-\ time\\:\\ 0\\.056715308640733285\ \(0\)\
\-\ shows\\:\\ 0\\.0561592096262514\ \(0\)\
\-\ lesions\\:\\ 0\\.054953364805601736\ \(0\)\
\-\ both\\:\\ 0\\.05335902853074333\ \(0\)\
\-\ metastatic\\:\\ 0\\.05247880253150798\ \(0\)\
\-\ bone\\:\\ 0\\.052209083022138454\ \(0\)\
\-\ noted\\:\\ 0\\.05073240129104385\ \(0\)\
\-\ woman\\:\\ 0\\.04983340897168129\ \(0\)\
\-\ diagnosis\\:\\ 0\\.04960277231342687\ \(0\)\
\-\ demonstrates\\:\\ 0\\.0480714393218157\ \(0\)\
\-\ to\\:\\ 0\\.04784245830094287\ \(0\)\
\-\ have\\:\\ 0\\.04780023988691099\ \(0\)\
\-\ surgical\\:\\ 0\\.04650635612216748\ \(0\)\
\-\ as\\:\\ 0\\.03844032892641653\ \(0\)\
\-\ ct\\:\\ 0\\.036428432342788135\ \(0\)\
\-\ at\\:\\ 0\\.036141688312342025\ \(0\)\
\-\ no\\:\\ 0\\.03111589059023793\ \(0\)\
\-\ for\\:\\ 0\\.029001591742308753\ \(0\)\
\-\ on\\:\\ 0\\.02889871428210819\ \(0\)\
\-\ in\\:\\ 0\\.023803488910135385\ \(0\)\
\-\ with\\:\\ 0\\.01873645012502191\ \(0\)\
\-\ of\\:\\ 0\\.018725261785567018\ \(0\)\
